NO760367L - - Google Patents

Info

Publication number
NO760367L
NO760367L NO760367A NO760367A NO760367L NO 760367 L NO760367 L NO 760367L NO 760367 A NO760367 A NO 760367A NO 760367 A NO760367 A NO 760367A NO 760367 L NO760367 L NO 760367L
Authority
NO
Norway
Application number
NO760367A
Other languages
Norwegian (no)
Other versions
NO146045B (no
NO146045C (no
Inventor
W Clauss
U Speck
D Jentsch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO760367L publication Critical patent/NO760367L/no
Publication of NO146045B publication Critical patent/NO146045B/no
Publication of NO146045C publication Critical patent/NO146045C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/90In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO760367A 1975-02-05 1976-02-04 Oralt roentgenkontrastmiddel for cholecystangiografi NO146045C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752505218 DE2505218A1 (de) 1975-02-05 1975-02-05 Neue orale roentgenkontrastmittel und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
NO760367L true NO760367L (nl) 1976-08-06
NO146045B NO146045B (no) 1982-04-13
NO146045C NO146045C (no) 1982-08-04

Family

ID=5938374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO760367A NO146045C (no) 1975-02-05 1976-02-04 Oralt roentgenkontrastmiddel for cholecystangiografi

Country Status (15)

Country Link
US (1) US4101647A (nl)
JP (1) JPS51104020A (nl)
AT (1) AT355202B (nl)
BE (1) BE838293A (nl)
CH (1) CH630262A5 (nl)
DE (1) DE2505218A1 (nl)
DK (1) DK147671C (nl)
FR (1) FR2299854A1 (nl)
GB (1) GB1542677A (nl)
IE (1) IE42950B1 (nl)
IT (1) IT1055049B (nl)
LU (1) LU74303A1 (nl)
NL (1) NL7601051A (nl)
NO (1) NO146045C (nl)
SE (1) SE436686B (nl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR830001643B1 (ko) * 1978-07-04 1983-08-22 울프 블릭스 X-선 조영제의 생리적으로 허용되는 멸균 주사용 용액을 제조하는 방법
DE3064989D1 (en) * 1979-02-19 1983-11-03 Chemie Linz Ag A liquid composition for use in rapid oral cholecystography and process for preparing it
US4455292A (en) * 1982-04-05 1984-06-19 Board Of Regents, The University Of Texas System Radiological contrast composition and methods
US4405575A (en) * 1982-04-23 1983-09-20 Henderson Albert E Method of defluorinating phosphates
US5948387A (en) * 1990-06-01 1999-09-07 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
US5420176A (en) * 1990-06-01 1995-05-30 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
AU650466B2 (en) * 1990-06-01 1994-06-23 Evan C. Unger Contrast media for ultrasonic imaging
DE4316722A1 (de) * 1993-05-19 1994-11-24 Fresenius Ag Parenteral verabreichbare, unter Hitzesterilisationsbedingungen stabile O/W-Emulsion eines Röntgenkontrastmittels
IT1316031B1 (it) * 2000-12-19 2003-03-26 Trelleborg Wheel Systems S P A Procedimento per radiografare i tessuti di rinforzo tessili neipneumatici e nei manufatti in genere realizzati con detti tessuti.
US20050255175A1 (en) * 2004-05-17 2005-11-17 Burgess W P Method for protecting nephron against injury caused by disruption of a chemical environment in the kidneys
US7019035B2 (en) * 2004-05-17 2006-03-28 Md Scientific Llc Method for attenuating free radical formation resulting from bodily insult
US20050255176A1 (en) * 2004-05-17 2005-11-17 Burgess W P Method for attenuating free radical formation resulting from bodily insult
US7625586B2 (en) 2004-10-28 2009-12-01 Md Scientific, Llc Method for mitigating injury to a kidney resulting from an ischemic event
EP2825064A1 (en) * 2012-03-15 2015-01-21 Fresenius Kabi Deutschland GmbH Compositions for dysphagia assessment
US9827265B1 (en) 2012-04-06 2017-11-28 Md Scientific, Llc Method for attenuating free radical formation resulting from a bodily insult
RU2683568C1 (ru) * 2013-12-04 2019-03-29 Ховионе Сайентиа Лимитед Композиции, корригирующие вкус контрастных средств

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2940996A (en) * 1960-06-14 M-hocbhxchzch
US2307189A (en) * 1940-03-02 1943-01-05 Bell William X-ray contrast composition
US2659690A (en) * 1950-06-08 1953-11-17 Elmer H Slaybaugh Effervescent barium sulfate-pectin x-ray contrast composition
US2996433A (en) * 1958-09-11 1961-08-15 Sterling Drug Inc Radiopaque formulations
US3359278A (en) * 1963-05-24 1967-12-19 Mallinckrodt Chemical Works Nu-substituted-2, 4, 6-triiodoanilic acids and salts thereof
FR1437666A (fr) * 1965-03-25 1966-05-06 Schering Ag Forme d'application pour agents de contraste radiologiques administrés par voie perorale
CH483261A (de) * 1967-05-29 1969-12-31 Bracco Ind Chimica Spa Neue Röntgenkontrastmittel und Verfahren zu ihrer Herstellung
GB1268188A (en) * 1968-06-11 1972-03-22 Nyegaard & Co As N-hydroxyalkyl-2,4,6-triiodosuccinanilic acids and their use as x-ray contrast agents

Also Published As

Publication number Publication date
ATA78176A (de) 1979-07-15
IE42950B1 (en) 1980-11-19
SE7601197L (sv) 1976-08-06
FR2299854A1 (fr) 1976-09-03
NO146045B (no) 1982-04-13
NL7601051A (nl) 1976-08-09
JPS51104020A (nl) 1976-09-14
US4101647A (en) 1978-07-18
GB1542677A (en) 1979-03-21
CH630262A5 (de) 1982-06-15
FR2299854B1 (nl) 1978-08-18
NO146045C (no) 1982-08-04
BE838293A (fr) 1976-08-05
DE2505218A1 (de) 1976-08-19
DK147671C (da) 1985-05-28
DK47576A (da) 1976-08-06
AT355202B (de) 1980-02-25
IE42950L (en) 1976-08-05
DK147671B (da) 1984-11-12
LU74303A1 (nl) 1976-06-18
SE436686B (sv) 1985-01-21
IT1055049B (it) 1981-12-21

Similar Documents

Publication Publication Date Title
JPS51104020A (nl)
JPS5550796B2 (nl)
FR2322892B1 (nl)
JPS5616515Y2 (nl)
JPS523385U (nl)
JPS5244984U (nl)
JPS51112132U (nl)
JPS5410444Y2 (nl)
JPS5441198Y2 (nl)
JPS51104168U (nl)
JPS51111373U (nl)
JPS5272370U (nl)
JPS5267872U (nl)
JPS51129771U (nl)
JPS5277294U (nl)
JPS51139619U (nl)
BG23472A1 (nl)
CH603100A5 (nl)
BG22659A1 (nl)
BG22542A1 (nl)
BG22152A1 (nl)
BG23334A1 (nl)
CH600292A5 (nl)
CH601117A5 (nl)
CH607238A5 (nl)